VVZ API is not affiliated with ETH Zurich. Data might be outdated or incorrect. Please view the official ETHZ Vorlesungsverzeichnis for binding information.
Pharmacovigilance
Last Updated: 2026-06-01 11:33:49
Abstract
The course in Pharmacovigilance (PV) provides basic knowledge and solid practical foundations for those who are seeking to work in PV and it will benefit those who are starting their career in other areas in the pharmaceutical industry. The course covers the principles of PV, its regulations, the principles of risk management, Quality Management, and inspections by Health Authorities.
Objective
Students - have a profound understanding of the importance of Pharmacovigilance and can explain the basic principles. - can define the relevant terms used in Pharmacovigilance. - know how to comply with the regulatory requirements. - can describe the requirements for safety reporting. - can show the different phases of the Signal Management process. - are familiar with measures to manage and minimize risks. - can demonstrate the relevance of a Quality Management System. - can describe the principles of Phamacovigilance Inspections. - are able to identify Adverse Effects associated with a drug and can demonstrate the necessary actions.
Content
- General introduction, terms and definitions of Pharmacovigilance - Regulatory environment: Legal requirements (with main focus on the EU and Switzerland) - Reporting requirements in clinical trials - Reporting requirements post‐marketing - Periodic Safety Reports: PSUR / PBRER; DSUR - Risk Management Plans (RMP) - Signal Detection and Management - Risk Management and Risk Communication (e.g. Warning Letter) - Quality Management System: SOPs and KPI’s - Pharmacovigilance Inspections and Audits - Corrective and Preventive Actions (CAPA) - Automation and Artificial Intelligence in PV
Resources
Lecture Notes
Will be published on «mystudies».
Literature
Information is available on the official websites of the Health Authorities, e.g. European Medicines Agency (EMA), US Food and Drug Administration (FDA), Swissmedic, and other national Health Authorities. Additional information can be also found on the websites of institutions, e.g. the International Council for Harmonisation (ICH).
General Information
- Language
- English
- Levels
- MSC
- Frequency
- Yearly recurring
Examination
- Type
- graded semester performance
Registration & Places
Course Components
| Type | Title | Time & Place | Hours |
|---|---|---|---|
| lecture with exercise |
Pharmacovigilance
Block course (see special program)
Room HCP E47.2
|
No time listed | 12 h semesterly |
Offered In
-
-
-
-
Industry-Specific Training (Please consult schedule on the website of the study programme )
-
-
-